ApiJect CEO Expects Therapy to Blunt Coronavirus Death Rate by Summer

The video discusses the challenges and solutions in the fight against coronavirus, focusing on the need for surge capacity in drug packaging. It highlights the role of public-private partnerships in addressing supply chain issues and the involvement of HHS in pandemic preparedness. The timeline for developing therapies and vaccines is explored, emphasizing the importance of safety and speed. Innovations in packaging technology, such as using plastic vials, are presented as crucial for efficient vaccine distribution.

What role does the FDA play in the public-private partnership for COVID-19 vaccine development?

How does the government plan to ensure the safety of the vaccine before it is distributed?

What is the significance of the phrase 'Vaccines don't save lives, vaccinations save lives' in the context of the discussion?